Merck Sharp & Dohme LLC

MSD, known as Merck & Co. in the United States and Canada, is a research-intensive biopharmaceutical company that develops medicines and vaccines for people and animals. Founded in 1891, the company has more than 130 years of operating history and works across biopharmaceutical research and development, drug discovery, vaccine development, and the treatment of infectious disease. Its website is https://msd.com/.

Historic output includes streptomycin, a breakthrough antibiotic therapy that helped reduce tuberculosis deaths by nearly 50% by 1950. The current medicines and vaccines portfolio is described as one of the most diverse pipelines in the company's history, addressing serious health concerns in humans. Through MSD Animal Health, the company develops veterinary solutions supporting the bond between people and pets, protecting public health, ensuring food safety, and increasing protein supplies worldwide.

Technical work spans prevention and treatment of disease in humans and animals, animal health and veterinary science, and vaccine development. The company operates globally and in the United States and Canada, in sectors including biopharmaceuticals, healthcare, vaccines, food safety, and agriculture.

MSD states that it is guided by the philosophy that medicine is for the people, not for the profits, and aspires to be the premier research-intensive biopharmaceutical company. It describes its approach as following the science where it can make the greatest difference, with commitments extending beyond medicines to public health, food safety, and the human-animal bond.